Clinical Trial Update: Tarlatamab for SCLC Brain Metastases [Phase 2]

View source ↗

Summary

Maastricht University Medical Center is conducting a Phase 2 trial of tarlatamab for adults with small cell lung cancer and brain metastases; the study is not y…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Brain Metastases
• Small Cell Lung Cancer

Drugs mentioned

• Tarlatamab

Snippet

Sponsor: Maastricht University Medical Center | Conditions: Small Cell Lung Cancer, Brain Metastases, Adult | Phase 2 | Status: NOT_YET_RECRUITING